Visualitza VHIO - Articles científics per autor "FARID, EL HAJBI"
Ara mostrant els elements 1-1 d 1
-
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study
Ajani, Jaffer A; FARID, EL HAJBI; Cunningham, David; Thuss-Patience, Peter; Scagliotti, Giorgio; Alsina, Maria (Elsevier, 2024-01)